APOE and Alzheimer disease: Our behavioral results indicate that 10‐month‐old E3‐AD mice have not yet exhibited significant cognitive impairments, whereas E4‐AD mice at the same age are inclined to demonstrate cognitive deficits in the Y‐maze test, suggesting that APOE4 accelerates the progression of AD.